☰

NomiBiotechCorporation

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of NomiBiotechCorporation's published strategy and is not endorsed by, or produced in cooperation with, NomiBiotechCorporation. Company website

Strategic priorities

NomiBiotechCorporation operates across 4 stated priorities, with the most concrete near-term plan anchored on scientific innovation & ip development.

use proprietary NOMICU® L-100 water-dispersible curcumin technology with patent-pending formulations, pursuing high-value research in antiviral applications, rare diseases (CCHS), and oncology enhancement.

Operating dual business models—B2B ingredient sales to supplement manufacturers via Knowde platform, and B2C functional beverages (Alcorythm®, Milcu®) through retail channels like Żabka and Allegro.

Navigating complex Novel Food regulations across EU, UK, Taiwan, and UAE markets while maintaining EFSA compliance for health claims management.

Challenges we see

  • Operations Integration

    Operational Entity Bifurcation

    Nomi Biotech and its spin-off Dairy Biotechnologies operate as separate legal entities in different locations (Złotniki vs. Puławy), sharing core IP and leadership but lacking unified operational systems.

    Without a unified ERP system, data regarding inventory, financial transfer pricing, and shared R&D resources becomes fragmented, creating compliance risks and inefficiencies that slow decision-making.

  • Operations Supply Chain

    Asia-Poland Supply Chain Opacity

    The Company sources raw materials from Taiwan and Japan, creating a geographically stretched supply chain vulnerable to maritime disruption, geopolitical risks, and quality control gaps.

    Reliance on paper-based Certificates of Analysis and manual quality verification drives extended quarantine times, stockout risks at retail partners like Żabka, and the risk of delisting penalties.

  • Compliance Regulatory

    Novel Food Regulatory Data Burden

    Operating in the highly regulated Novel Food space requires managing complex EFSA dossiers, toxicological studies, and market-specific ingredient approvals across multiple jurisdictions.

    Manual, document-based management of regulatory submissions creates inefficiency, slows market entry, and increases the risk of compliance failures or mislabeled health claims.

  • Digital R&D

    Joining records across systems

    High-complexity biomedical research (antiviral, oncology, rare diseases) generates massive heterogeneous datasets including genomic sequences, microscopy images, and clinical data stored across disparate systems.

    Reliance on non-validated storage and disparate hard drives threatens IP integrity, weakens patent defense, and jeopardizes future due diligence by investors.

  • Digital Sales

    Fragmented Commercial Channels

    B2B ingredient sales via Knowde platform are disconnected from internal sales teams, while B2C products face price sensitivity and lack customer loyalty mechanisms.

    Digital leads from Knowde may be lost in spreadsheets, the long B2B sales cycle lacks CRM tracking, and Alcorythm® pricing challenges remain unaddressed without customer data insights.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Unified Multi-Entity Operations

    Nomi Biotech and Dairy Biotechnologies operate with fragmented systems despite sharing IP and leadership, creating data latency, compliance risks, and administrative overhead.

    Implement a cloud-based ERP solution that provides a single digital backbone spanning both entities, enabling real-time financial consolidation, unified inventory visibility, and streamlined reporting.

  2. Supply Chain Visibility & Quality Control

    Manual Certificate of Analysis handling and lack of real-time logistics visibility across the Taiwan-Japan-Poland supply chain creates stockout risks and extended quality verification times.

    Deploy a Supply Chain Control Tower with digital quality network allowing Asian suppliers to upload batch data pre-shipment, enabling remote quality pre-clearance and reducing quarantine time.

  3. Regulatory Dossier Management

    Managing Novel Food applications, EFSA submissions, and multi-jurisdiction compliance through manual document processes creates inefficiency and delays market entry.

    Implement a Regulatory Information Management (RIM) system to centralize all product dossiers, automate submission tracking, and generate compliant document packages for new market entry.

  4. R&D Data Governance & IP Protection

    High-value research data from antiviral and oncology studies is stored in silos without proper audit trails, risking IP integrity and complicating patent defense.

    Deploy an Electronic Lab Notebook (ELN) and LIMS environment to digitize the entire R&D workflow, ensure ALCOA+ compliance, and create defensible audit trails for patent protection.

  5. B2B Lead Conversion & Customer Engagement

    Disconnect between Knowde digital leads and internal sales teams creates lost opportunities, while B2C price sensitivity and lack of loyalty programs limit customer lifetime value.

    Integrate a CRM system with Knowde API for lead scoring and deploy a Customer Data Platform (CDP) for personalized engagement, loyalty programs, and connected packaging initiatives.

What we'd propose

  • Digital Lab

    Bio-Unified ERP Platform

    Implementation of a scalable Cloud ERP tailored for life sciences to create a single digital backbone spanning Nomi Biotech and Dairy Biotechnologies, consolidating financial, inventory, and operational data.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital Lab

    Regulatory Information Management (RIM) System

    Cloud-based regulatory information management system to centralize all Novel Food dossiers, certificates, and safety data with automated tracking and compliant document generation.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital Lab

    R&D Data Harmonization Platform

    Deployment of an Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) to digitize research workflows, ensure data integrity, and protect intellectual property.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Supply Chain Control Tower

    Digital supply chain collaboration platform providing real-time visibility into Asia-Poland logistics with integrated quality management and supplier collaboration capabilities.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    Customer Intelligence Platform

    Integrated CRM and Customer Data Platform connecting B2B lead sources with sales operations and enabling personalized B2C customer engagement through data-driven insights.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what NomiBiotechCorporation's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 25 → 75
Operations fragmented between Nomi and Dairy Biotechnologies entities; R&D data stored in silos without unified platform
Process Automation 30 → 70
Manual CoA handling, paper-based regulatory submissions, disconnected sales processes
Supply Chain Visibility 20 → 80
Limited real-time visibility into Asia-Poland logistics; manual quality verification processes
Regulatory Compliance 40 → 85
Basic compliance achieved but manual dossier management; risk of errors in multi-jurisdiction filings
Customer Intelligence 25 → 70
Disconnected B2B leads from sales team; limited B2C loyalty mechanisms; no unified customer view
IP & Data Governance 35 → 85
High-value research data lacks proper audit trails; patent defense documentation not systematized

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with NomiBiotechCorporation, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].